Stella Vnook begun her career as a scientist/ healthcare provider and with over 25-year pharmaceutical journey, she transformed to a well-established CEO/ Biotech Founder.
She began her Pharma career at Merck & Co., where she spent 15 years and now she is focused on building Biotech start ups and helping companies realize their full growth potential. Stella is a Founder of MaiCell Therapeutics, a Xenotransplantation cell-based company and NAKI Therapeutics with innovative CAR-NK technology.
Prior to that, she was an executive on the ground floor of building Catalent to an exit, Jay Pharma/ Enveric exit to IPO, played a critical role in forming the Merck/Schering-Plough JV, and Jazz Pharma. Stella has a BA/BS in Biology/Anthropology, and Pharmacy, specializing in Oncology, and an MBA in Marketing.